Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity

NCT00414531 is registered in ClinicalTrials.gov with University of Oslo School of Pharmacy as lead sponsor.

NCT NCT00414531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00414531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity
Lead sponsor
University of Oslo School of Pharmacy
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
June 30, 2009
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myotoxicity of atorvastatin treatment